Sign in Sign up for free

Last updated: 8 February 2021 at 4:48pm EST

Abba Poliakoff Net Worth




The estimated Net Worth of Abba David Poliakoff is at least $408 Thousand dollars as of 19 January 2021. Mr. Poliakoff owns over 30,000 units of Champions Oncology Inc stock worth over $366,898 and over the last 16 years he sold CSBR stock worth over $0. In addition, he makes $41,020 as Independent Director at Champions Oncology Inc.

Mr. Poliakoff CSBR stock SEC Form 4 insiders trading

Abba has made over 2 trades of the Champions Oncology Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 30,000 units of CSBR stock worth $102,300 on 19 January 2021.

The largest trade he's ever made was exercising 50,000 units of Champions Oncology Inc stock on 1 January 2012 worth over $8,500. On average, Abba trades about 5,333 units every 220 days since 2008. As of 19 January 2021 he still owns at least 90,147 units of Champions Oncology Inc stock.

You can see the complete history of Mr. Poliakoff stock trades at the bottom of the page.





Abba Poliakoff biography

Abba David Poliakoff serves as Independent Director of the Company. Mr. Poliakoff is a member of the law firm of Gordon Feinblatt LLC in Baltimore, Maryland, and chair of its Securities Law Group. He is a member of the Maryland State Bar Association’s Business Law Section, former Chair of its Committee on Securities, and a former member of the Business Regulations Article Review Committee of the Committee to Revise the Maryland Annotated Code. Mr. Poliakoff is the Chairman Emeritus of the Maryland Israel Development Center, a joint venture between the State of Maryland Department of Business and Economic Development and the State of Israel Ministry of Industry and Trade. Governor Lawrence J. Hogan, Jr. has appointed Mr. Poliakoff to co-chair the Business Regulation Review Commission. Previously, Governor Martin J. O’Malley of Maryland has appointed Mr. Poliakoff to the Governor’s International Advisory Council on International Commerce and Trade. Before that, he was appointed by Maryland Governor Robert C. Ehrlich, Jr. to the Governor’s Transition Committee. He currently serves on a number of boards, including the board of visitors of the University of Maryland School of Medicine, the board of directors of the BioTechnical Institute of Maryland, the board of directors of the JET Incubator of Baltimore and on several advisory boards. In his community work, he is Vice President and on the board of directors of the Baltimore Jewish Council, on the board of directors of The Associated Jewish Community Federation of Baltimore, and a founder and past president of the Jewish Arbitration and Mediation Board of Baltimore. He is also on the board of directors of Levindale Hebrew Geriatric Center and Hospital, a member company of LifeBridge Health, and on the Investment Committee of LifeBridge Health.

What is the salary of Abba Poliakoff?

As the Independent Director of Champions Oncology Inc, the total compensation of Abba Poliakoff at Champions Oncology Inc is $41,020. There are 5 executives at Champions Oncology Inc getting paid more, with Ronnie Morris having the highest compensation of $1,343,650.



How old is Abba Poliakoff?

Abba Poliakoff is 68, he's been the Independent Director of Champions Oncology Inc since 2008. There are no older and 9 younger executives at Champions Oncology Inc.

What's Abba Poliakoff's mailing address?

Abba's mailing address filed with the SEC is C/O CHAMPIONS ONCOLOGY, INC., ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK, NJ, 07601.

Insiders trading at Champions Oncology Inc

Over the last 21 years, insiders at Champions Oncology Inc have traded over $9,072,751 worth of Champions Oncology Inc stock and bought 42,104,566 units worth $13,657,266 . The most active insiders traders include Ventures Ix, L.P.Battery In..., Michael Maurice Brown, and Sports Inc Champions. On average, Champions Oncology Inc executives and independent directors trade stock every 76 days with the average trade being worth of $2,196,294. The most recent stock trade was executed by Daniel Newman Mendelson on 12 January 2024, trading 1,000 units of CSBR stock currently worth $6,500.



What does Champions Oncology Inc do?

champions oncology, inc. is engaged in the development of advanced technology solutions to personalize the development and use of oncology drugs. champions tumorgraft™ technology platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments, or tumorgrafts, in a manner that preserves the biological characteristics of the original human tumor. champions believes that these tumorgrafts, unlike cell line derived xenografts used in tradition testing, closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. the company offers personalized tumorgraft development, drug studies and genome sequencing as part of its personalized oncology solutions ("pos") whereby physicians can evaluate the effects of cancer drugs on their patients' tumorgrafts and understand the genetic make-up of their patient's tumor enabling them



What does Champions Oncology Inc's logo look like?

Champions Oncology Inc logo

Complete history of Mr. Poliakoff stock trades at Champions Oncology Inc

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
19 Jan 2021 CSBR Champions Oncology Inc Abba David Poliakoff
Director
 Option 30,000 $3.41 $102,300
19 Jan 2021
90,147 ↗
1 Jan 2012 CSBR Champions Oncology Inc Abba David Poliakoff
Director
 Option 50,000 $0.17 $8,500
1 Jan 2012
600,000 ↗


Champions Oncology Inc executives and stock owners

Champions Oncology Inc executives and other stock owners filed with the SEC include: